Market Overview

Benzinga's Top Upgrades

Share:
Benzinga's Top Upgrades
Related GS
How Does A Bank Exec Turned Fintech CEO Plan Out A Workday?
'He Made Me Want To Be Part Of Something Bigger Than Myself': Colleagues Remember Fintech Pioneer Neil DeSena
Take The Road Less Traveled (Seeking Alpha)
Related CRL
A Peek Into The Markets: U.S. Stock Futures Edge Lower Ahead Of Yellen Speech
Earnings Scheduled For February 14, 2017
Charles River Laboratories Is A Wonderful Business At A Wonderful Price (Seeking Alpha)

 

  • Deutsche Bank upgraded Goldman Sachs Group Inc (NYSE: GS) from Hold to Buy. The price target for Goldman Sachs has been raised from $180 to $255. Goldman Sachs shares rose 0.94 percent to $213.75 in pre-market trading.
  • Barclays upgraded Charles River Laboratories Intl. Inc (NYSE: CRL) from Underweight to Equal-Weight. Charles River shares closed at $71.56 on Tuesday.
  • Goldman Sachs upgraded Celanese Corporation (NYSE: CE) from Neutral to Buy. The price target for Celanese has been raised from $83 to $92. Celanese shares rose 0.73 percent to close at $77.16 on Tuesday.
  • Analysts at Berenberg upgraded Teck Resources Ltd (USA) (NYSE: TCK) from Sell to Hold. Teck Resources shares gained 1.27 percent to $25.52 in pre-market trading.
  • Analysts at BMO Capital upgraded Mid-America Apartment Communities Inc (NYSE: MAA) from Market Perform to Outperform. Mid-America Apartment shares rose 0.66 percent to $94.43 in pre-market trading.
  • Mizuho upgraded UnitedHealth Group Inc (NYSE: UNH) from Neutral to Buy. UnitedHealth shares rose 0.36 percent to $158.16 in pre-market trading.
  • Analysts at DA Davidson upgraded Super Micro Computer, Inc. (NASDAQ: SMCI) from Neutral to Buy. The price target for Super Micro Computer has been raised from $25 to $32. Super Micro Computer shares gained 2.49 percent to $26.75 in pre-market trading.
  • Analysts at Chardan Capital upgraded Arbutus Biopharma Corp (NASDAQ: ABUS) from Neutral to Buy. The price target for Arbutus Biopharma has been raised from $3 to $4. Arbutus Biopharma shares rose 9.43 percent to $2.90 in pre-market trading.
  • JP Morgan upgraded SBA Communications Corporation (NASDAQ: SBAC) from Neutral to Overweight. SBA Communications shares rose 0.19 percent to close at $99.81 on Tuesday.

Latest Ratings for GS

DateFirmActionFromTo
Jan 2017CitigroupDowngradesNeutralSell
Dec 2016Atlantic EquitiesDowngradesOverweightNeutral
Dec 2016HSBCInitiates Coverage OnBuy

View More Analyst Ratings for GS
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (CE + ABUS)

View Comments and Join the Discussion!